Compare Heron Therapeutics Inc (HRTX) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Williams Companies Inc — how do they compare? Heron Therapeutics Inc trades at $0.47 (market cap $91.46M), while Williams Companies Inc trades at $73.62 (market cap $90.70B). The key difference: Williams Companies Inc is far larger — about 991.7× Heron Therapeutics Inc's market cap, and Williams Companies Inc pays a 2.83% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | WMB | |
|---|---|---|
Market Cap | $91.46M | $90.70B |
Sector | Health | Energy |
52-Week High | $1.96 | $79.40 |
52-Week Low | $0.39 | $56.51 |
Enterprise Value | $189.36M | $120.08B |
Dividend Yield | — | 2.83% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
WMB trades at $74.57, up 1.62% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported revenue of $11.95B in 2025 with a net income margin of 23.4% and recently secured a $5.34 billion Blackstone-led investment for power projects. Analyst consensus is strongly bullish with a $86.00 price target and 79% buy ratings.
The outlook is supported by strategic investments in energy infrastructure and stable cash flows, but risks include high debt levels and sensitivity to natural gas prices. The stock offers a dividend yield and growth potential from LNG expansion, though recent earnings misses warrant monitoring execution on new projects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
